A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF).
conjunctival ultraviolet autofluorescence
environmental factors
genetics
high myopia
myopia
outdoor activities
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
22 Jul 2022
22 Jul 2022
Historique:
received:
25
06
2022
revised:
20
07
2022
accepted:
20
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Myopia is the most common refractive error worldwide. This cannot be explained by genetic factors alone, therefore, environmental factors may play an important role. Hence, the main objective of this study was to analyse whether outdoor exposure could exert a protective effect against the development of myopia in a cohort of young adults and to investigate ultraviolet autofluorescence (CUVAF), as a biomarker of time spent outdoors. A cross-sectional observational study was carried out using two cohorts. A total of 208 participants were recruited, 156 medical students and 52 environmental science students. The data showed that 66.66% of the medical students were myopic, while 50% of the environmental science students were myopic (p = 0.021). Environmental science students spent significantly more hours per week doing outdoor activities than medical students (p < 0.0001), but there was no significant difference with respect to near work activities between them. In both cohorts, the degree of myopia was inversely associated with CUVAF, and a statistically significant positive correlation was observed between spherical equivalent and CUVAF (Pearson’s r = 0.248). In conclusion, outdoor activities could reduce the onset and progression of myopia not only in children, but also in young adults. In addition, CUVAF represents an objective, non-invasive biomarker of outdoor exposure that is inversely associated with myopia.
Identifiants
pubmed: 35893353
pii: jcm11154264
doi: 10.3390/jcm11154264
pmc: PMC9331436
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI20/00251
Organisme : European Regional Development Fund "A way to make Europe"
ID : PI20/00251
Organisme : Fundación Jesús Gangoiti Barrera
ID : 2020-2021
Organisme : a collaborative project with Multiópticas
ID : CUN 2019
Organisme : Red Temática de Investigación Cooperativa en Salud: 'Prevention, Early Detection and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology'
ID : RD16/0008/0011
Organisme : Redes de Investigación Cooperativa Orientadas al Resultado en Salud (RICORS) de Terapias avanzadas
ID : RD21/0017/0027
Organisme : Enfermedades Inflamatorias
ID : RD21/0002/0010
Organisme : Enfermedades vasculares cerebrales
ID : RD21/0006/0008
Références
Acta Ophthalmol. 2017 Sep;95(6):551-566
pubmed: 28251836
Cont Lens Anterior Eye. 2014 Dec;37(6):427-30
pubmed: 25127093
Clin Exp Ophthalmol. 2019 May;47(4):445-452
pubmed: 30345715
Optom Vis Sci. 2019 Apr;96(4):276-282
pubmed: 30907857
Am J Ophthalmol. 2014 Nov;158(5):1079-85
pubmed: 25072831
Eye (Lond). 2011 Jul;25(7):893-900
pubmed: 21494284
Ophthalmic Physiol Opt. 2013 May;33(3):339-45
pubmed: 23510367
Am J Ophthalmol. 2015 May;159(5):877-83.e7
pubmed: 25634530
Curr Eye Res. 2021 Oct;46(10):1474-1481
pubmed: 33646852
JAMA. 2015 Sep 15;314(11):1142-8
pubmed: 26372583
JAMA Ophthalmol. 2022 Feb 01;140(2):162-169
pubmed: 34989764
Ophthalmology. 2015 Jul;122(7):1489-97
pubmed: 25983215
J Mod Opt. 2013 Oct 1;60(14):1200-1208
pubmed: 25342873
Front Public Health. 2022 Apr 27;10:861044
pubmed: 35570945
JAMA Ophthalmol. 2015 Apr;133(4):406-12
pubmed: 25590795
PLoS One. 2015 Aug 05;10(8):e0134514
pubmed: 26244865
Prog Retin Eye Res. 2019 Mar;69:80-115
pubmed: 30391362
Clin Exp Optom. 2019 Jan;102(1):43-50
pubmed: 30114725
BMC Ophthalmol. 2015 Jul 09;15:73
pubmed: 26152123
Sci Rep. 2021 Mar 18;11(1):6337
pubmed: 33737652
Medicine (Baltimore). 2019 Mar;98(10):e14777
pubmed: 30855486
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Ophthalmic Physiol Opt. 2016 Jul;36(4):359-69
pubmed: 27350182
Invest Ophthalmol Vis Sci. 2013 Feb 05;54(2):1026-33
pubmed: 23322575
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2903-10
pubmed: 18579757
Ophthalmology. 2013 Oct;120(10):2100-8
pubmed: 23672971
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Eye (Lond). 2012 Jul;26(7):911-8
pubmed: 22562184
Ophthalmology. 2013 May;120(5):1080-5
pubmed: 23462271
Invest Ophthalmol Vis Sci. 2012 Jul 01;53(8):4363-70
pubmed: 22669720
Ophthalmology. 2018 Aug;125(8):1239-1250
pubmed: 29371008
Optom Vis Sci. 1996 Jul;73(7):495-8
pubmed: 8843130
JAMA Ophthalmol. 2017 Jan 01;135(1):47-53
pubmed: 27918775
PLoS One. 2015 Oct 20;10(10):e0140419
pubmed: 26485393
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M184-M203
pubmed: 30817832
Am J Ophthalmol. 2006 Feb;141(2):294-8
pubmed: 16458683
Ophthalmology. 2008 Aug;115(8):1279-85
pubmed: 18294691
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1322-7
pubmed: 18385044
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):163-8
pubmed: 22678717
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1146-1153
pubmed: 28446546
Am J Optom Physiol Opt. 1987 Jul;64(7):545-54
pubmed: 3307441